What should you know about metastatic lung cancer life expectancy?

Metastatic lung cancer includes different subtypes and molecular profiles. The sites and amount of spread, symptoms, fitness, other health conditions and how the cancer responds to treatment all influence what happens next. These factors can change over time, so an estimate is a clinical conversation rather than a fixed prediction.

Ask your oncologist to explain the outlook in plain language and to separate what is known about your cancer from what remains uncertain. Genomic tumour profiling may identify information that affects treatment choices.

Treatment may aim to control cancer, ease symptoms, preserve independence or support a specific personal goal. Options can include chemotherapy, radiotherapy, selected surgery and medicines matched to tumour features. Palliative care can begin alongside active treatment to support pain, breathlessness, sleep, appetite, mood and family communication.

Bring a trusted person to appointments if helpful. Discuss advance care preferences, practical support, work or travel concerns, and how you want difficult updates shared. A plan can be revisited when symptoms, scans or treatment response change.

Seek urgent help for severe breathlessness, sudden weakness, new confusion, a seizure, severe chest pain or uncontrolled pain. Contact your oncology team promptly for coughing blood, fever during treatment, worsening hoarseness, new neurological symptoms or a rapid decline in daily function.

What features of my cancer most affect the outlook? What is the aim of the recommended treatment? How will response be assessed? Would genomic tumour profiling change my choices? When should palliative care be involved? Who should my family call if symptoms change suddenly?